We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
WA
1626
Winfield Associates
Ohio
$487K +$19.9K +632 +4%
GWI
1627
Grace & White Inc
New York
$483K
RGC
1628
Roberts, Glore & Co
Illinois
$482K +$30.7K +975 +7%
TDC
1629
Thompson Davis & Co
Virginia
$480K +$371K +11,804 +306%
SIG
1630
Schooner Investment Group
Pennsylvania
$479K -$1.33M -42,160 -73%
RCG
1631
Ruane, Cunniff & Goldfarb
New York
$479K +$118K +3,740 +31%
SFU
1632
Stonehage Fleming (UK)
United Kingdom
$478K
BRA
1633
Bender Robert & Associates
California
$473K +$34.8K +1,107 +8%
CA
1634
Cambridge Advisors
Nebraska
$471K -$35.3K -1,121 -7%
IC
1635
IKOS CIF
Cyprus
$470K +$163K +5,166 +52%
S
1636
SignatureFD
Georgia
$467K +$83.6K +2,657 +21%
IFAM
1637
Institutional & Family Asset Management
Colorado
$462K +$474K +15,081 New
RMA
1638
Roffman Miller Associates
Pennsylvania
$458K +$48.6K +1,544 +12%
CA
1639
Cornerstone Advisory
Maryland
$457K +$470K +14,935 New
RTS
1640
Round Table Services
New Jersey
$456K +$87.6K +2,783 +23%
JGIA
1641
Jackson Grant Investment Advisers
Connecticut
$455K +$467K +14,846 New
DCM
1642
Donaldson Capital Management
Indiana
$454K -$560K -17,810 -55%
CAM
1643
Chesapeake Asset Management
New York
$453K -$49.6K -1,576 -10%
AT
1644
Acadia Trust
Maine
$451K -$12.5K -397 -3%
BB
1645
Bell Bank
North Dakota
$451K -$12.1K -386 -3%
GAM
1646
Griffin Asset Management
New York
$449K -$289K -9,179 -38%
FWSM
1647
First Wilshire Securities Management
California
$449K
CCM
1648
Carlson Capital Management
Minnesota
$445K +$346 +11 +0.1%
PJSIMP
1649
P.J. Schmidt Investment Management (PJS)
Wisconsin
$445K +$113K +3,588 +33%
CS
1650
Cannell & Spears
New York
$443K -$24.9K -790 -5%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.